+84.6%
GSK vs EOSE
-85.2%
+169.8%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | EOSE | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.3% | -0.7% | -0.7% | -1.3% |
| 7D | -3.1% | -25.6% | +22.5% | -2.9% |
| 30D | -0.9% | -18.2% | +17.3% | -0.8% |
| 3M | -4.2% | -59.7% | +55.5% | -3.6% |
| 6M | -1.6% | -80.1% | +78.5% | -0.4% |
| YTD | +2.6% | -87.1% | +89.7% | +3.8% |
| 1Y | +6.2% | -89.0% | +95.2% | +7.6% |
| 3Y | +55.0% | +26.5% | +28.5% | +49.1% |
| 5Y | +42.8% | -85.0% | +127.8% | +35.8% |
| All | +84.6% | -85.2% | +169.8% | +85.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EOSE.
Daily Out/Under-Performance
Portfolio return minus EOSE return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EOSE return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded EOSE wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling